Mutlu Hayran
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 8
- Oncology top 5%
- Cancer Treatment and Pharmacology 7
- Dermatology top 5%
-
- Lymphoma Diagnosis and Treatment 7
-
- Neonatal Respiratory Health Research 5
-
- Smoking Behavior and Cessation 9
-
- Autoimmune and Inflammatory Disorders Research 5
-
- Breast Cancer Treatment Studies 5
-
- Pregnancy and preeclampsia studies 5
- Co-authors
- Başak YalçınÖmer DızdarNuran AllıSercan AksoyEmine TamerPınar ÖztaşHakan HarputluoğluÖmrüm Uzun
- Journals
- Journal of Clinical Oncology (7 papers)Medical Oncology (4 papers)Clinical Rheumatology (3 papers)
- Partner nations
- TürkiyeUnited StatesItaly
In The Last Decade
Mutlu Hayran
149 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 140
- Otorhinolaryngology 168
- Oncology 723
- Dermatology 175
- Pathology and Forensic Medicine 310
- Pulmonary and Respiratory Medicine 563
Countries citing papers authored by Mutlu Hayran
This map shows the geographic impact of Mutlu Hayran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mutlu Hayran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mutlu Hayran more than expected).
Fields of papers citing papers by Mutlu Hayran
This network shows the impact of papers produced by Mutlu Hayran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mutlu Hayran. The network helps show where Mutlu Hayran may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mutlu Hayran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 29 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 11 | |
| 6 | 2020 | 4 | |
| 7 | 2019 | 18 | |
| 8 | 2019 | 7 | |
| 9 | 2018 | 2 | |
| 10 | Biyotıp Araştırmalarında Klinik Araştırma Etik Kurulları | 2018 | 1 |
| 11 | 2014 | 4 | |
| 12 | 2013 | 23 | |
| 13 | 2013 | 4 | |
| 14 | 65 Yaş ve üzeri popülasyonda kanser sıklığının dağılımı: Hacettepe Üniversitesi Hastaneleri kanser kayıt sistemi sonuçları | 2011 | 0 |
| 15 | 2009 | 40 | |
| 16 | 2009 | 14 | |
| 17 | 2009 | 29 | |
| 18 | 2009 | 19 | |
| 19 | 2008 | 19 | |
| 20 | 2007 | 13 |
About Mutlu Hayran
Mutlu Hayran is a scholar working on Otorhinolaryngology, Oncology, Periodontics, Hematology and Pulmonary and Respiratory Medicine, having authored 157 papers that have together received 2.9k indexed citations. Recurring topics across this work include Smoking Behavior and Cessation (9 papers), Head and Neck Cancer Studies (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Cancer Treatment and Pharmacology (7 papers), Autoimmune and Inflammatory Disorders Research (5 papers), Neonatal Respiratory Health Research (5 papers), Breast Cancer Treatment Studies (5 papers) and Pregnancy and preeclampsia studies (5 papers). The work is most often cited by research in Otorhinolaryngology (168 citations), Oncology (723 citations), Dermatology (175 citations), Pathology and Forensic Medicine (310 citations) and Pulmonary and Respiratory Medicine (563 citations). Mutlu Hayran has collaborated with scholars based in Türkiye, United States and Italy. Frequent co-authors include Başak Yalçın, Ömer Dızdar, Nuran Allı, Sercan Aksoy, Emine Tamer, Pınar Öztaş, Hakan Harputluoğlu, Ömrüm Uzun, Gülnur Güler and Serhat Ünal. Their work appears in journals such as Journal of Clinical Oncology, Medical Oncology, Clinical Rheumatology, Pediatric Nephrology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.